SELZENTRY is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Maraviroc.
Product ID | 50090-1486_074b036c-dfce-4827-9586-2d67f95891b2 |
NDC | 50090-1486 |
Product Type | Human Prescription Drug |
Proprietary Name | SELZENTRY |
Generic Name | Maraviroc |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-05-16 |
Marketing Category | NDA / NDA |
Application Number | NDA022128 |
Labeler Name | A-S Medication Solutions |
Substance Name | MARAVIROC |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-12-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022128 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-12-03 |
Marketing End Date | 2019-10-31 |
Ingredient | Strength |
---|---|
MARAVIROC | 300 mg/1 |
SPL SET ID: | e6f47a2b-98e8-4c16-9f41-72dfe2fd5389 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
49702-223 | SELZENTRY | maraviroc |
49702-224 | SELZENTRY | maraviroc |
49702-233 | SELZENTRY | maraviroc |
49702-235 | SELZENTRY | maraviroc |
49702-237 | SELZENTRY | maraviroc |
49702-260 | SELZENTRY | maraviroc |
50090-1486 | SELZENTRY | maraviroc |
50090-6238 | SELZENTRY | maraviroc |
31722-579 | Maraviroc | Maraviroc |
31722-580 | Maraviroc | Maraviroc |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SELZENTRY 77183318 3372315 Live/Registered |
PHIVCO-1 LLC 2007-05-17 |